Probiotics and Risk of Death, Necrotizing Enterocolitis, and Sepsis in Very Preterm Infants
Probiotika und Risiko für Tod, nekrotisierende Enterokolitis und Sepsis bei sehr früh geborenen Säuglingen
JAMA Network Open · 23.09.2026 · 9 (9) · e2635560
DOI: 10.1001/jamanetworkopen.2026.35560 ↗Auf einen Blick
In einer populationsbasierten Kohortenstudie war Probiotika-Supplementierung bei sehr früh geborenen Säuglingen mit geringerem Risiko für Tod und/oder NEC verbunden. Für Tod und/oder kulturgesicherte Sepsis zeigte sich kein Zusammenhang.
Fragestellung
Ist eine Probiotika-Supplementierung bei sehr früh geborenen Säuglingen mit dem Risiko für Tod, nekrotisierende Enterokolitis und/oder kulturgesicherte Sepsis assoziiert?
Methode
Populationsbasierte Kohortenstudie mit Daten aus dem Swedish Neonatal Quality Register vom 1. Januar 2017 bis 31. Dezember 2024; sehr früh geborene Lebendgeborene mit Ausschlüssen; multivariable Regressions- und Matching-Analysen.
Ergebnisse
Bei 4.695 Säuglingen war Probiotika-Supplementierung mit niedrigerem Risiko für Tod und/oder NEC verbunden: 0,8 % vs. 3,4 %; ARR 0,28 (95 %-KI 0,14–0,56). Auch Tod und NEC traten seltener auf. Sepsis: kein Zusammenhang.
Einschränkungen
Übertragbarkeit laut Autor:innen nicht auf extrem früh geborene Kinder <28 Schwangerschaftswochen.
Schlussfolgerung der Autor:innen
Die Implementierung eines multistammigen Probiotikums war mit einer deutlichen Verringerung von Tod und/oder NEC verbunden und kann die gemeinsame Entscheidungsfindung unterstützen.
Kernaussagen
- Tod und/oder NEC: 0,8 % vs. 3,4 %; ARR 0,28 (95 %-KI 0,14–0,56)
- Tod: 0,3 % vs. 1,4 %; NEC: 0,6 % vs. 2,5 %
- Kein Zusammenhang mit Tod und/oder kulturgesicherter Sepsis
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 23.09.2026. Verfasst von Ayoub Mitha und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Probiotics, Enterocolitis, Necrotizing, Sepsis, Infant, Extremely Premature. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Neonatologie, Sepsis
Abstract (Originalsprache)
Importance Probiotics are reported to benefit preterm infants, but population-based clinical evidence is limited. In 2020, the Swedish Neonatal Society issued a national recommendation to supplement very preterm infants (28 weeks 0 days’ to 31 weeks 6 days’ gestation) with probiotics.
Objective
To investigate whether probiotic supplementation was associated with risk of death, necrotizing enterocolitis (NEC), and/or culture-proven sepsis in infants born very preterm. Design, Setting, and Participants This population-based cohort study examined data from the Swedish Neonatal Quality Register from January 1, 2017, through December 31, 2024. Live-born, very preterm infants, excluding those who died within the first 3 days of life or due to congenital or chromosomal abnormalities, were included. Exposure Daily probiotic supplementation of 1 billion colony-forming units of freeze-dried Bifidobacterium infantis , Bifidobacterium lactis , and Streptococcus thermophilus initiated following birth and discontinued at postmenstrual week 34. Main Outcomes and Measures Composites of death and/or NEC (Bell stage 2-3), death and/or surgical NEC (Bell stage 3), and death and/or culture-proven sepsis were assessed. Modified Poisson regression, propensity score–matched, and inverse probability of treatment weighting analyses were used for replication analyses. A multivariate bayesian modeling analysis accounting for the association between NEC and mortality was performed to estimate the association between probiotic exposure and mortality.
Results
Among 4695 infants (mean [SD] gestational age, 30.2 [1.1] weeks; 2550 male [54.3%]), probiotic exposure increased from 0% before the national recommendation in 2020 to 16.9% in 2020 and a mean (SD) of 64.8% (4.7%) in 2021 to 2024. Probiotic supplementation vs no supplementation was associated with lower risk of death and/or NEC (rate, 0.8% vs 3.4%; adjusted relative risk [ARR], 0.28 [95% CI, 0.14-0.56]). When assessed separately, risks of death (rate, 0.3% vs 1.4%; ARR, 0.16 [95% CI, 0.06-0.45]) and NEC (rate, 0.6% vs 2.5%; ARR, 0.25 [95% CI, 0.10-0.61]) were both lower in the probiotic group. Multivariate bayesian modeling suggested that a substantial proportion of the observed mortality reduction was mediated via reduced NEC incidence (42.3% [credible interval, 16.1%-100%]). Probiotic supplementation was not associated with death and/or culture-proven sepsis (rate, 3.4% vs 4.4%; ARR, 0.86 [95% CI, 0.58-1.26]). Conclusions and Relevance This cohort study of very preterm infants found that implementation of a multistrain probiotic was associated with a significant reduction in death and/or NEC, which may help inform shared decision-making between clinicians and families. These results should not be generalized to extremely preterm infants (<28 weeks’ gestation).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
- Department of Neonatal Medicine, Bretonneau Hospital, François Rabelais University, CHU Tours, Tours, France.
- Université Paris Cité and Université Sorbonne Paris Nord, Inserm, INRAE, Center for Research in Epidemiology and Statistics, Obstetric, Perinatal, Paediatric Life Course Epidemiology Research Team, Paris, France.
- Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
- Women's Health and Allied Health Professional Theme, Karolinska University Hospital, Solna, Stockholm, Sweden.
- Centre for Epidemiology and Community Medicine, Region Stockholm, Stockholm, Sweden.
Zitieren
APA
Mitha, A., Söderquist Kruth, S., Sinervo, E., Domellöf, M., Brindefalk, B., Abrahamsson, T., Johansson, S., & Rakow, A. (2026). Probiotics and Risk of Death, Necrotizing Enterocolitis, and Sepsis in Very Preterm Infants. JAMA Network Open, 9(9), e2635560. https://doi.org/10.1001/jamanetworkopen.2026.35560
Vancouver
Mitha A, Söderquist Kruth S, Sinervo E, Domellöf M, Brindefalk B, Abrahamsson T, et al. Probiotics and Risk of Death, Necrotizing Enterocolitis, and Sepsis in Very Preterm Infants. JAMA Network Open. 2026;9(9):e2635560. doi:10.1001/jamanetworkopen.2026.35560
BibTeX
@article{Mitha2026,
author = {Mitha, Ayoub and Söderquist Kruth, Sofia and Sinervo, Emma and Domellöf, Magnus and Brindefalk, Björn and Abrahamsson, Thomas and Johansson, Stefan and Rakow, Alexander},
title = {Probiotics and Risk of Death, Necrotizing Enterocolitis, and Sepsis in Very Preterm Infants},
journal = {JAMA Network Open},
year = {2026},
volume = {9},
number = {9},
pages = {e2635560},
doi = {10.1001/jamanetworkopen.2026.35560}
}
EUVIMED